Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: A new class of β-glucuronidase inhibitors and in silico studies

Abstract A library of novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone (3a-3r) was synthesized and evaluated for their potential as β-glucuronidase inhibitors. Several compounds such as 3a-3d, 3e-3j, 3l-3o, 3q and 3r showed excellent inhibitory potentials much better than the sta...

Full description

Bibliographic Details
Published in:Bioorganic and Medicinal Chemistry
Main Author: Zawawi N.K.N.A.; Taha M.; Ahmat N.; Wadood A.; Ismail N.H.; Rahim F.; Ali M.; Abdullah N.; Khan K.M.
Format: Article
Language:English
Published: Elsevier Ltd 2015
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937437445&doi=10.1016%2fj.bmc.2015.04.081&partnerID=40&md5=9b76ed8fe1d93152c79a084d6a809102
id 2-s2.0-84937437445
spelling 2-s2.0-84937437445
Zawawi N.K.N.A.; Taha M.; Ahmat N.; Wadood A.; Ismail N.H.; Rahim F.; Ali M.; Abdullah N.; Khan K.M.
Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: A new class of β-glucuronidase inhibitors and in silico studies
2015
Bioorganic and Medicinal Chemistry
23
13
10.1016/j.bmc.2015.04.081
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937437445&doi=10.1016%2fj.bmc.2015.04.081&partnerID=40&md5=9b76ed8fe1d93152c79a084d6a809102
Abstract A library of novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone (3a-3r) was synthesized and evaluated for their potential as β-glucuronidase inhibitors. Several compounds such as 3a-3d, 3e-3j, 3l-3o, 3q and 3r showed excellent inhibitory potentials much better than the standard (IC50 = 48.4 ± 1.25 μM: d-saccharic acid 1,4-lactone). All the synthesized compounds were characterized satisfactorily by using different spectroscopic methods. We further evaluated the interaction of the active compounds and the enzyme active site with the help of docking studies. © 2015 Elsevier Ltd.
Elsevier Ltd
9680896
English
Article

author Zawawi N.K.N.A.; Taha M.; Ahmat N.; Wadood A.; Ismail N.H.; Rahim F.; Ali M.; Abdullah N.; Khan K.M.
spellingShingle Zawawi N.K.N.A.; Taha M.; Ahmat N.; Wadood A.; Ismail N.H.; Rahim F.; Ali M.; Abdullah N.; Khan K.M.
Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: A new class of β-glucuronidase inhibitors and in silico studies
author_facet Zawawi N.K.N.A.; Taha M.; Ahmat N.; Wadood A.; Ismail N.H.; Rahim F.; Ali M.; Abdullah N.; Khan K.M.
author_sort Zawawi N.K.N.A.; Taha M.; Ahmat N.; Wadood A.; Ismail N.H.; Rahim F.; Ali M.; Abdullah N.; Khan K.M.
title Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: A new class of β-glucuronidase inhibitors and in silico studies
title_short Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: A new class of β-glucuronidase inhibitors and in silico studies
title_full Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: A new class of β-glucuronidase inhibitors and in silico studies
title_fullStr Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: A new class of β-glucuronidase inhibitors and in silico studies
title_full_unstemmed Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: A new class of β-glucuronidase inhibitors and in silico studies
title_sort Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: A new class of β-glucuronidase inhibitors and in silico studies
publishDate 2015
container_title Bioorganic and Medicinal Chemistry
container_volume 23
container_issue 13
doi_str_mv 10.1016/j.bmc.2015.04.081
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937437445&doi=10.1016%2fj.bmc.2015.04.081&partnerID=40&md5=9b76ed8fe1d93152c79a084d6a809102
description Abstract A library of novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone (3a-3r) was synthesized and evaluated for their potential as β-glucuronidase inhibitors. Several compounds such as 3a-3d, 3e-3j, 3l-3o, 3q and 3r showed excellent inhibitory potentials much better than the standard (IC50 = 48.4 ± 1.25 μM: d-saccharic acid 1,4-lactone). All the synthesized compounds were characterized satisfactorily by using different spectroscopic methods. We further evaluated the interaction of the active compounds and the enzyme active site with the help of docking studies. © 2015 Elsevier Ltd.
publisher Elsevier Ltd
issn 9680896
language English
format Article
accesstype
record_format scopus
collection Scopus
_version_ 1809678486553493504